| Literature DB >> 19173718 |
Olga Kolaj1, Stefania Spada, Sylvain Robin, J Gerard Wall.
Abstract
Despite the fundamental importance of E. coli in the manufacture of a wide range of biotechnological and biomedical products, extensive process and/or target optimisation is routinely required in order to achieve functional yields in excess of low mg/l levels. Molecular chaperones and folding catalysts appear to present a panacea for problems of heterologous protein folding in the organism, due largely to their broad substrate range compared with, e.g., protein-specific mutagenesis approaches. Painstaking investigation of chaperone overproduction has, however, met with mixed - and largely unpredictable - results to date. The past 5 years have nevertheless seen an explosion in interest in exploiting the native folding modulators of E. coli, and particularly cocktails thereof, driven largely by the availability of plasmid systems that facilitate simultaneous, non-rational screening of multiple chaperones during recombinant protein expression. As interest in using E. coli to produce recombinant membrane proteins and even glycoproteins grows, approaches to reduce aggregation, delay host cell lysis and optimise expression of difficult-to-express recombinant proteins will become even more critical over the coming years. In this review, we critically evaluate the performance of molecular chaperones and folding catalysts native to E. coli in improving functional production of heterologous proteins in the bacterium and we discuss how they might best be exploited to provide increased amounts of correctly-folded, active protein for biochemical and biophysical studies.Entities:
Year: 2009 PMID: 19173718 PMCID: PMC2642769 DOI: 10.1186/1475-2859-8-9
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Figure 1The process of protein folding in the . Nascent polypeptides encounter trigger factor (TF) chaperone upon emerging from the ribosomal exit tunnel (1). They can also be captured by DnaK (2) which cooperates with its cofactor DnaJ and nucleotide exchange factor GrpE to promote folding to a native (3) or partially folded conformation. The latter may be re-captured by DnaK (4) and possibly TF to repeat this folding cycle until it reaches its native state, interact with GroEL-GroES (5) to complete folding to its native conformation, or undergo aggregation (6). Upon heat stress, partial unfolding of thermolabile proteins can occur, resulting in exposure of aggregation-prone hydrophobic regions (7). sHsps such as IbpA and IbpB act to "hold" partially unfolded proteins for transfer to Hsp70 and Hsp60 chaperones DnaK and GroEL (8,9), while disaggregation of unfolded proteins is carried out by ClpB in cooperation with the Hsp70 family (10), followed again by their transfer to the DnaK/DnaJ/GrpE machinery for completion of folding.
Proteins whose total and/or functional yields increase upon co-production of GroESL
| Human procollagenase | GroESL increased production levels by 10-fold, solubility and half-life | [ |
| p50csk Protein-Tyrosine Kinase | Co-production enhanced solubility and activity of the protein by up to >50% | [ |
| 2-fold increase in protein solubility | [ | |
| Several hundred-fold increase in PCC specific activity; most of the protein produced in soluble form | [ | |
| Human electron transfer flavoprotein (ETF) | Co-production required for stable expression of ETF α G116R mutant | [ |
| Co-production resulted in slower growth rate and reduced yield but increased solubility of the proteins by 20–60% at 37°C and up to 70% at 25°C | [ | |
| Cryj2 Japanese cedar pollen | Increased yield and solubility of expressed protein; 4-fold stabilisation of the protein in the presence of a 10-fold chaperone excess | [ |
| Human kinase inhibitor-GST fusion | Solubility of otherwise mostly insoluble protein enhanced by 5–6-fold | [ |
| Eukaryotic phenylalanine ammonia-lyase | Dramatically improved yield and activity of the protein after engineering of gene to remove | [ |
| Bovine adrenodoxin reductase (AdR) | Increased soluble AdR yield to 10 mg/l, compared with 4 mg/l with Hsp70 | [ |
| Cyanobacterium transcription factor | 3–4-fold increase in solubility | [ |
| Co-production of GroESL with tRNAAGA and tRNAAGG led to 5-fold increase in GTase activity in soluble fraction; yield otherwise lower and 60% insoluble | [ | |
| 4-fold increase in activity due to improved solubility | [ | |
| Human cytochrome P450 3A7 (CYP3A7) | Increased expression levels and activity of the otherwise inactive protein | [ |
| Decarboxylase component of human α-keto acid dehydrogenase complex | Co-production of GroEL or GroES resulted in increase in decarboxylase activity by 500-fold and 30-fold, respectively | [ |
| Maize plastidic protoporphyrinogen IX oxidase (PPO) | 6-fold increase in soluble PPO yield | [ |
| Manganese catalase from | Increased solubility (up to 50%) with GroESL | [ |
| p66 and p51 subunits of HIV-1 RTase | Yield and nucleic acid affinity increased by 4–5- and 1.6-fold, respectively | [ |
| Anti-digoxin Fab antibody fragment | 4-fold increase in solubility of the Fab produced in | [ |
| Increase in solubility of DCB up to 60% and activity by 6.2-fold at 28°C; at 25°C protein solubility increased to 75% and activity by 4.5-fold | [ | |
| Guinea pig NADPH:quinone oxidoreductase | 3-fold increase in solubility | [ |
| Aconitase | Solubility and activity increased to 40% and by 1.5-fold, respectively | [ |
| Solubility of the protein increased up to 40–50% and activity by 25-fold | [ | |
| Growth of host cells improved; 2.2-fold increase in yield of active GluR | [ | |
| With | [ | |
| Human PP2A methyltransferase | 24-fold increase in solubility | [ |
| Oligo-1,6-glucosidase from | Specific activity increased by 44%, 56% and 56% with co-production of GroES, GroEL and GroESL, respectively | [ |
| Cyclodextrin gluanotransferase (CGTase) from | Increase in solubility and activity of CGTase by 12% and 1.5-fold, respectively, at 37°C and by 22% and 1.3-fold, respectively, at 25°C | [ |
| At 30°C, improved folding and an increase in specific activity by 1.76-fold | [ | |
| Mouse CYP27B1 protein | 10-fold increase in the yield of stable and active protein | [ |
| Pyridoxine 4-oxidase (PNO) from | No benefit of GroESL at 37°C; co-production at 23°C enhanced solubility and specific activity of PNO by 1.9-fold and 3.9-fold, respectively | [ |
| Pyridoxal 4-dehydrogenase from | Co-production at 20°C led to reduced amounts of insoluble protein and increased specific activity by 9.1-fold | [ |
| Enzymatic activity of the proteins increased from 7.8 to 72.4 U/mg and 7.1 to 22.7 U/mg, respectively, at 30°C | [ | |
| Human aromatase (P450arom, CYP19) NmA264C and NmA264R mutants | No improvement with NmA264C; production of NmA264R greatly enhanced (up to 400 nmol/l) | [ |
| scFv specific for c-Met | Solubility increased 2-fold in | [ |
| Yeast mitochondrial aconitase | Increased solubility at 25°C with no change in total yield | [ |
| human prolyl hydroxylase isoenzyme | 2-fold increase in solubility when produced at 30°C | [ |
| Pig liver esterase γ-isoenzyme (PLE) | Enhanced yield of soluble and active PLE in | [ |
| Soybean seed ferritin complex | Increased solubility of H-1 subunit from 4 to 39% and H-2 subunit from 19 to 85% | [ |
| Human 11β hydroxylase | 20- to 40-fold increase in yield in half the production time | [ |
| Human glucose 6-phosphate dehydrogenase (G6PD) and mutants | Negligible effect on expression of wild type G6PD but activities of two mutants were enhanced by 48–160% and 39–118% at 37°C and 31°C, respectively | [ |
Figure 2Membrane translocation and periplasmic folding in . Most polypeptides cross the cytoplasmic membrane in an unfolded conformation using the Sec translocase (1), following delivery to SecA at the inner surface of the membrane by DnaK or SecB chaperones. Polypeptides with highly hydrophobic signal sequences or transmembrane domains may, however, be recognised by Ffh which, together with its FtsY receptor, can target the polypeptide to either the Sec machinery or to the YidC translocase (2). Alternatively, the twin-arginine translocation (Tat) machinery is responsible for the translocation of already folded proteins (3), typically with bound metal cofactors. After cleavage of the leader peptide upon crossing the membrane, partially folded proteins may (4) aggregate, (5) be degraded by periplasmic proteases, or fold into their native state, often with the assistance of periplasmic chaperones (6) and/or folding catalysts such as disulfide bond metabolising enzymes (7) or peptidyl-prolyl cis-trans isomerases (8).
Figure 3Strategy for selection of molecular chaperones and folding catalysts for co-production analyses. Following production of a recombinant protein in E. coli, analysis of cell growth, protein solubility and subcellular location, macromolecular state and activity provide some insight into the limiting step in the folding and production process. This Figure shows the major bottlenecks typically encountered (in hexagons) during production of a difficult-to-express recombinant target and identifies the co-production strategies that have been most successful in overcoming these bottlenecks to date (corresponding ovals).